| Positive Rankings |
Target Prices
The average analysts' target price is $20.50 for Cara Therapeutics Inc. using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Cara Therapeutics Inc. is ranked 348. |
10 Day Gain
Cara Therapeutics Inc. rank is 432 |
Low Put/Call
Cara Therapeutics Inc. has a low Put/Call ratio of 0.37 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Cara Therapeutics Inc. is ranked 1039. |
| Negative Rankings |
Overbought Stochastics
Cara Therapeutics Inc. rank is 617 |
90 Day Loss
Cara Therapeutics Inc. rank is 1139 |
High vPut/Call
Cara Therapeutics Inc. has a high Put/Call ratio of 0.61 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Cara Therapeutics Inc. is ranked 1814. |
